Argus Partners advised MEDGENOME Inc.(MedGenome), a leading, genomic diagnostics and research services company, on its Series E fundraise of approximately USD 47.5 million. The round was co-led by Maj Invest, along-with existing investor Novo Holdings and saw participation from Sofina Ventures, also an existing investor in MedGenome.
The fundraise will enable MedGenome to broaden access to its genomics and integrated diagnostics solutions across India and other emerging markets. The funding will further strengthen MedGenome’s efforts to reduce India’s disease burden through early detection and targeted disease management using affordable, genetics-based diagnostic tools.
The team at Argus Partners advising MedGenome consisted of Partners Abhinav Bhalaik, & Armaan Patkar, Senior Associate Ishita Agarwal and Associate Anoushka Goel.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.
